1/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education

1/2：UHCOP-DLDCCC 联盟：癌症药物发现/开发和教育

基本信息

批准号：
9789213
负责人：
Jason Yustein
金额：
$ 3.11万
依托单位：
UNIVERSITY OF HOUSTON
依托单位国家：
美国
项目类别：
财政年份：
资助国家：
美国
起止时间：
至
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/9789213
关键词：
Address Antineoplastic Agents Area Awareness Bioinformatics Biological Sciences Biometry Collaborations Communication Community Outreach Comprehensive Cancer Center Cultural Diversity Cultural Sensitivity Development Discipline Doctor of Pharmacy Doctor of Philosophy Education Educational Curriculum Educational workshop Electronic Mail Emerging Technologies Engineering Environment Exposure to Faculty Fellowship Fostering Future GRE Preparation Goals Grant Individual Infrastructure Institutes Institution International Joints Knowledge Malignant Neoplasms Medicine Mentors Methods Participant Pharmacy facility Physics Pilot Projects Postdoctoral Fellow Readiness Reporting Research Research Personnel Schools Science Series Social Sciences Students Training Underrepresented Students Underserved Population Universities anticancer research cancer health disparity career career development college design drug development drug discovery education research experience faculty research graduate student health disparity interest member mid-career faculty multidisciplinary outreach outreach program professor programs recruit research and development research facility science education skills social media undergraduate research undergraduate student university student web site

项目摘要

! PROJECT SUMMARY (CREP) The overall goal of the collaborative cancer research education program (CREP) between University of Houston (UH) and the NCI-designated Dan L. Duncan Comprehensive Cancer Center (DLDCCC) at Baylor College of Medicine (BCM) is to encourage and prepare underrepresented (UR) undergraduate and graduate students to enter careers in cancer research. We propose to provide cancer research experiences, develop new cancer-specific curricula, and create educational outreach efforts to UR students through independent, yet complementary aims. While the overall P20 collaboration will be between UH College of Pharmacy (UHCOP) and DLDCCC, the collaborative CREP will engage undergraduate students at UH and graduate students conducting cancer research at UH and BCM. First, we will enhance the cancer research experience of undergraduate and graduate students. This will be done by (1) providing UH undergraduate students with research experience in the area of cancer drug discovery and development at both UH and DLDCCC, (2) providing access to core research facilities in a cross-institutional manner and by shared membership of thesis committee to augment the research capabilities and exposure of the graduate students at UH and DLDCCC, and (3) utilizing myNRMN and mentoring modules developed by National Research Mentoring Network (NRMN) for research mentors to effectively address cultural diversity matters in research mentoring relationships. Second, we will develop new cancer research curricula and methods for undergraduate and graduate students. Here, we will develop a multi-disciplinary seminar series on cancer research to expose UH undergraduate students to multiple areas of cancer research and a new joint course on “emerging technologies in cancer drug discovery/development” that will significantly contribute to the existing curriculum of graduate students at both UH and DLDCCC/BCM. Third, we will prepare culturally diverse health disparity aware cancer researchers. This will be done by enhancing access of UR students to mentoring and career development activities such as a newly created “Lunch with Cancer Researchers” series featuring other UR cancer researchers in various stages of their career, a GRE prep course for undergraduates, and professional development workshop on grant/fellowship development for graduate students. To increase awareness of cancer health disparities, we will also launch a new seminar series on cancer health disparities at DLDCCC and provide community outreach opportunities for CREP participants through engagement in Theater Outreach Program organized by the Office out Outreach and Health Disparity at DLDCCC. In summary, our collaborative CREP will establish the critical infrastructure needed to support a long-term sustained effort for increasing the pipeline of UR trainees in cancer research and also to bolster submission of future training grants at institution level and fellowship/career development grants at the trainee level.

！项目概要 (CREP) 癌症研究合作教育计划（CREP）的总体目标休斯顿 (UH) 和 NCI 指定的贝勒 Dan L. Duncan 综合癌症中心 (DLDCCC) 医学院 (BCM) 旨在鼓励和培养代表性不足 (UR) 的本科生和研究生我们建议学生进入癌症研究领域，提供癌症研究经验，发展。新的针对癌症的课程，并通过独立但尚未完成的方式为 UR 学生开展教育推广工作总体而言，P20 合作将由夏威夷大学药学院 (UHCOP) 之间进行。和 DLDCCC，合作 CREP 将吸引 UH 的本科生和研究生在 UH 和 BCM 进行癌症研究首先，我们将增强癌症研究经验。这将通过 (1) 为 UH 本科生提供在 UH 和 DLDCCC 的癌症药物发现和开发领域的研究经验，(2) 以跨机构的方式和论文的共享成员资格提供对核心研究设施的访问委员会旨在增强 UH 和 DLDCCC 研究生的研究能力和接触机会， (3) 利用国家研究指导网络开发的 myNRMN 和指导模块 (NRMN) 让研究导师在研究指导中有效解决文化多样性问题其次，我们将为本科生和学生开发新的癌症研究课程和方法。在这里，我们将举办一个关于癌症研究的多学科研讨会系列，以揭露呃。本科生对癌症研究的多个领域以及“新兴技术”的新联合课程癌症药物发现/开发”，这将对研究生现有课程做出重大贡献第三，我们将为具有文化多样性的健康差异意识的癌症做好准备。这将通过增强 UR 学生获得指导和职业发展的机会来实现。活动，例如新创建的“与癌症研究人员共进午餐”系列，以其他 UR 癌症为主题处于职业生涯各个阶段的研究人员、本科生 GRE 预备课程以及专业人士关于研究生资助/奖学金发展的发展研讨会，以提高对研究生的认识。癌症健康差异，我们还将在 DLDCCC 推出关于癌症健康差异的新系列研讨会并通过参与剧院外展活动为 CREP 参与者提供社区外展机会 DLDCCC 外展和健康差异办公室组织的计划总之，我们的合作。 CREP 将建立必要的关键基础设施，以支持长期持续的努力，以增加 UR 癌症研究受训人员的管道，并支持机构未来培训补助金的提交实习生级别和研究金/职业发展补助金。